SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001192482-18-000391
Filing Date
2018-08-13
Accepted
2018-08-13 14:24:53
Documents
1
Effectiveness Date
2018-08-13
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14789
  Complete submission text file 0001192482-18-000391.txt   15912
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-292766 | Film No.: 181011821
SIC: 2834 Pharmaceutical Preparations